-
-
-
-
-
-
-
Dermira (DERM) Says Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
-
-
-
-
-
-
-
Dermira (DERM) Presents New Data Highlighting Patient Outcomes in Axillary Hyperhidrosis at Maui Derm Meeting
-
-
-
-
-
-
-
Dermira (DERM) Positive Ph 3 Results for DRM04, PT to $46 - Needham & Company
-
-
-
-
-
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

